Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 8 Biopsy 8 pembrolizumab 6 Cyclophosphamide 6 X-Rays 5 Phantoms, Imaging 5 Doxorubicin 5 Nuclear Medicine Department, Hospital 4 fludarabine 3 Radiation 3 Irinotecan 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 liposomal doxorubicin 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 ensartinib 2 atezolizumab 2 anlotinib 2 Temozolomide 2 Surveys and Questionnaires 2 Radiotherapy 2 Ifosfamide 2 Gemcitabine 2 Fluorodeoxyglucose F18 2 Carboplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × penpulimab × 30 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡